Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas

Authors

Emre Kocakavuk
Kevin C. Johnson
Thais S. Sabedot, Henry Ford HealthFollow
Hans Christian Reinhardt
Houtan Noushmehr, Henry Ford HealthFollow
Roel G. W Verhaak

Recommended Citation

Kocakavuk E, Johnson KC, Sabedot TS, Reinhardt HC, Noushmehr H, and Verhaak RGW. Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas. Neuro Oncol 2023.

Document Type

Article

Publication Date

6-17-2023

Publication Title

Neuro Oncol

PubMed ID

37329568

ePublication

ePub ahead of print